Majzner, R. G., Ramakrishna, S., Mochizuki, A., Patel, S., Chinnasamy, H., Yeom, K., … Monje, M. (2021). GD2 CAR T cells mediate clinical activity and manageable toxicity in children and young adults with DIPG and H3K27M-mutated diffuse midline gliomas. In CANCER RESEARCH (Vol. 81).

Majzner, Robbie G., Sneha Ramakrishna, Aaron Mochizuki, Shabnum Patel, Harshini Chinnasamy, Kristen Yeom, Liora Schultz, et al. “GD2 CAR T cells mediate clinical activity and manageable toxicity in children and young adults with DIPG and H3K27M-mutated diffuse midline gliomas.” In CANCER RESEARCH, Vol. 81, 2021.

Majzner RG, Ramakrishna S, Mochizuki A, Patel S, Chinnasamy H, Yeom K, et al. GD2 CAR T cells mediate clinical activity and manageable toxicity in children and young adults with DIPG and H3K27M-mutated diffuse midline gliomas. In: CANCER RESEARCH. 2021.

Majzner, Robbie G., et al. “GD2 CAR T cells mediate clinical activity and manageable toxicity in children and young adults with DIPG and H3K27M-mutated diffuse midline gliomas.” CANCER RESEARCH, vol. 81, no. 13, 2021.

Majzner RG, Ramakrishna S, Mochizuki A, Patel S, Chinnasamy H, Yeom K, Schultz L, Richards R, Campen C, Reschke A, Mahdi J, Toland AMS, Baggott C, Mavroukakis S, Egeler E, Moon J, Landrum K, Erickson C, Rasmussen L, Barsan V, Tamaresis JS, Marcy AC, Kunicki M, Fujimoto M, Ehlinger Z, Kurra S, Cornell T, Partap S, Fisher P, Grant G, Vogel H, Sahaf B, Davis K, Feldman S, Mackall CL, Monje M. GD2 CAR T cells mediate clinical activity and manageable toxicity in children and young adults with DIPG and H3K27M-mutated diffuse midline gliomas. CANCER RESEARCH. 2021.